Müller, Markus
Niemeyer, Konstantin
Ojha, Navin K. https://orcid.org/0000-0001-9225-4267
Porav, Sebastian A. https://orcid.org/0000-0003-4238-0083
Vinayagam, Deivanayagabarathy https://orcid.org/0000-0001-7862-9499
Urban, Nicole https://orcid.org/0000-0001-5516-7922
Büchau, Fanny
Oleinikov, Katharina
Makke, Mazen
Bauer, Claudia C. https://orcid.org/0000-0003-4278-4803
Johnson, Aidan V. https://orcid.org/0000-0003-0303-9106
Muench, Stephen P. https://orcid.org/0000-0001-6869-4414
Zufall, Frank https://orcid.org/0000-0002-4383-8618
Bruns, Dieter
Schwarz, Yvonne
Raunser, Stefan https://orcid.org/0000-0001-9373-3016
Leinders-Zufall, Trese https://orcid.org/0000-0002-0678-362X
Bon, Robin S. https://orcid.org/0000-0003-1733-3680
Schaefer, Michael https://orcid.org/0000-0003-3662-4387
Thorn-Seshold, Oliver https://orcid.org/0000-0003-3981-651X
Article History
Received: 29 December 2024
Accepted: 31 October 2025
First Online: 16 January 2026
Competing interests
: R.S.B. is a cofounder and partner of the pharmaceutical start-up company CalTIC. R.S.B. and S.A.P. have received funding from CalTIC. The other authors declare no competing interests.